文献速递白内障与屈光手术眼底病与葡萄膜炎

SIRT1 抑制高糖诱导的 TXNIP/NLRP3 炎症小体激活与白内障形成

SIRT1 Inhibits High Glucose-Induced TXNIP/NLRP3 Inflammasome Activation and Cataract Formation.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

研究在人晶状体上皮细胞(HLECs)和大鼠晶状体中探讨 SIRT1 是否通过调控 TXNIP/NLRP3 炎症小体影响高糖诱导的炎症与白内障形成。结果显示高糖呈浓度依赖性降低 SIRT1 并激活 TXNIP/NLRP3 炎症小体,SIRT1 为其上游负调控因子,MCC950 或 SRT1720 可防止大鼠晶状体混浊与白内障形成。

要点

  • 高糖应激在 HLECs 中呈浓度依赖性诱导 SIRT1 表达下降及 TXNIP/NLRP3 炎症小体激活。
  • 敲低 NLRP3 或 TXNIP 可抑制高糖应激下 NLRP3 炎症小体诱导的 IL-1β p17 分泌。
  • MCC950 或 SRT1720 处理可防止高糖培养大鼠晶状体的晶状体混浊与白内障形成。

核心结论

  • TXNIP/NLRP3 炎症小体通路促进高糖诱导的炎症和 HLEC 焦亡,该通路受 SIRT1 负向调控,提示糖尿病性白内障的可行治疗策略。

研究设计与样本

  • 体外研究:对 HLECs 施加 25 至 150 mM 高糖应激,并使用靶向 NLRP3、TXNIP 和 SIRT1 的小干扰 RNA(siRNA)及 SIRT1 慢病毒载体(LV)处理。
  • 体外研究:大鼠晶状体在高糖培养基中培养,添加或不添加 NLRP3 抑制剂 MCC950 或 SIRT1 激动剂 SRT1720,并设高甘露醇组作为渗透压对照。
  • 检测方法包括实时 PCR、Western blot 和免疫荧光染色评估 SIRT1、TXNIP、NLRP3、ASC 和 IL-1β 的 mRNA 与蛋白水平,并评估活性氧(ROS)生成、细胞活力和细胞死亡。

主要发现

  • 高糖应激在 HLECs 中呈浓度依赖性诱导 SIRT1 表达下降并导致 TXNIP/NLRP3 炎症小体激活,高甘露醇处理组未观察到该现象。
  • 敲低 NLRP3 或 TXNIP 可抑制高糖应激下 NLRP3 炎症小体诱导的 IL-1β p17 分泌。
  • 转染 si-SIRT1 和 LV-SIRT1 对 NLRP3 炎症小体激活产生相反效应,提示 SIRT1 作为 TXNIP/NLRP3 活性的上游调控因子。
  • 高糖应激诱导培养大鼠晶状体发生晶状体混浊和白内障形成,MCC950 或 SRT1720 处理可防止该现象,并伴随 ROS 生成及 TXNIP/NLRP3/IL-1β 表达水平降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether SIRT1 regulates high glucose (HG)-induced inflammation and cataract formation through modulating TXNIP/NLRP3 inflammasome activation in human lens epithelial cells (HLECs) and rat lenses. METHODS: HG stress from 25 to 150 mM was imposed on HLECs, with treatments using small interfering RNAs (siRNAs) targeting NLRP3, TXNIP, and SIRT1, as well as a lentiviral vector (LV) for SIRT1. Rat lenses were cultivated with HG media, with or without the addition of NLRP3 inhibitor MCC950 or SIRT1 agonist SRT1720. High mannitol groups were applied as the osmotic controls. Real-time PCR, Western blots, and immunofluorescent staining evaluated the mRNA and protein levels of SIRT1, TXNIP, NLRP3, ASC, and IL-1β. Reactive oxygen species (ROS) generation, cell viability, and death were also assessed. RESULTS: HG stress induced a decline in SIRT1 expression and caused TXNIP/NLRP3 inflammasome activation in a concentration-dependent manner in HLECs, which was not observed in the high mannitol-treated groups. Knocking down NLRP3 or TXNIP inhibited NLRP3 inflammasome-induced IL-1β p17 secretion under HG stress. Transfections of si-SIRT1 and LV-SIRT1 exerted inverse effects on NLRP3 inflammasome activation, suggesting that SIRT1 acts as an upstream regulator of TXNIP/NLRP3 activity. HG stress induced lens opacity and cataract formation in cultivated rat lenses, which was prevented by MCC950 or SRT1720 treatment, with concomitant reductions in ROS production and TXNIP/NLRP3/IL-1β expression levels. CONCLUSIONS: The TXNIP/NLRP3 inflammasome pathway promotes HG-induced inflammation and HLEC pyroptosis, which is negatively regulated by SIRT1. This suggests viable strategies for treating diabetic cataract.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Lian L, Le Z, Wang Z, et al. SIRT1 Inhibits High Glucose-Induced TXNIP/NLRP3 Inflammasome Activation and Cataract Formation. Invest Ophthalmol Vis Sci. 2023. PMID: 36881408. doi:10.1167/iovs.64.3.16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。